Giorgia Guglielmi

Microbiota-derived molecule boosts effectiveness of Crohn’s disease treatment

L-ornithine can be an additional therapy to boost the efficacy of ustekinumab in people with Crohn’s disease.

The need for diversity in vaginal microbiota research

By addressing biases and increasing diversity in microbiota studies, researchers can develop more accurate and inclusive health strategies for women of different backgrounds.

Gut microbes linked to inflammatory bowel diseases worsen colitis in mice

Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, are long-term conditions involving gut inflammation caused by an excessive immune response. Now, a study done in mice found…

Sugary drinks may raise diabetes risk by altering gut bacteria

The findings of a recent study suggest a potential role of gut microbiota and microbial metabolites in the link between sugar-sweetened beverages intake and diabetes risk.

Global study reveals gaps in microbiota research

A new database of thousands of gut microbiota samples from across the word highlights the need for more diverse microbiota research across the globe.

Vaginal microbiota may be linked to increased Chlamydia infection risk

Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.

A high-fiber diet and beneficial bacteria may improve metabolic health

Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.

Gut microbes protect against colorectal cancer by regulating tumor-promoting gene

The microbiota plays a protective role against colorectal cancer by regulating Snhg9.

Newly discovered microbiota-derived bile acids may help treat metabolic conditions

By suggesting that BA–MCYs can regulate the production of bile acids, the findings of a recent study offer insights for treating metabolic conditions such as diabetes.

Commensal bacteria may help repair the skin’s barrier

Specific microbial metabolites can lead to new therapies for skin barrier disorders such as eczema and psoriasis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top